A Study of LY4175408 in Participants With Advanced Cancer
NCT07046923
This study is recruiting at 15 US sites in 13 states, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this study is to measure the safety and efficacy of LY4175408 in participants with selected advanced cancer. In addition, this study will evaluate how much LY4175408 gets into the bloodstream, how it is broken down, and how long it takes the body to get rid of it. Participation could last up to 4 years.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Carcinoma, Non-Small-Cell Lung
- Small Cell Lung Carcinoma
- Endometrial Neoplasms
- Neoplasm Metastasis
- Triple Negative Breast Cancer
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Eli Lilly and Company
- Last updated on ClinicalTrials.gov
- June 23, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
California · 1
- Stanford Medicine Cancer Center · Stanford, CA
Florida · 2
- Florida Cancer Specialists - Lake Nona - Sarah Cannon Research Institute · Orlando, FL
- Florida Cancer Specialists - Sarasota · Sarasota, FL
Illinois · 1
- The University of Chicago Medical Center (UCMC) · Chicago, IL
Indiana · 1
- Community Health Network · Indianapolis, IN
Massachusetts · 1
- Massachusetts General Hospital · Boston, MA
Missouri · 1
- Washington University · St Louis, MO
New Jersey · 1
- John Theurer Cancer Center At Hackensack UMC · Hackensack, NJ
New York · 2
- Columbia University · New York, NY
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center · New York, NY
Ohio · 1
- The Ohio State University (OSU) Wexner Medical Center · Columbus, OH
Tennessee · 1
- Sarah Cannon Research Institute · Nashville, TN
Texas · 1
- MD Anderson Cancer Center · Houston, TX
Utah · 1
- START Mountain Region · West Valley City, UT
Virginia · 1
- NEXT Virginia · Fairfax, VA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.